Over recent decades, the global burden of fungal disease has expanded dramatically. It is
estimated that fungal disease kills approximately 1.5 million individuals annually; however …

Immunocompromised host section: Adoptive T-cell therapy for... : Current Opinion in
Infectious Diseases Immunocompromised host section: Adoptive T-cell therapy for dsDNA …

Allogeneic hematopoietic cell transplantation (allo-HCT) recipients are susceptible to viral
infections. We conducted a phase 2 trial evaluating the safety and rate of clinically significant …

Cytomegalovirus (CMV), a member of the Herpesviridae family, is frequent among
hematopoietic cell transplant (HCT) and solid organ transplant (SOT) recipients in absence …

With an increasing number of risk groups for developing EBV PTLD in HCT and SOT,
management strategies using prophylaxis or preemptive therapy remain standard of care …

In recent years, fungal vaccine research emanated significant findings in the field of
antifungal T-cell immunity. The generation of effector T cells is essential to combat many …

Haploidentical stem cell transplantation (haplo-SCT), an alternative donor source, offers a
curative therapy for patients with acute myeloid leukemia (AML) who are transplant …

Infections with double-stranded DNA viruses are a significant cause of morbidity and
mortality in pediatric patients following allogeneic hematopoietic stem cell transplantation …

Adoptive immunotherapy with virus-specific cytotoxic T cells (VSTs) has evolved over the
last three decades as a strategy to rapidly restore virus-specific immunity to prevent or treat …

Solid organ transplant recipients require ongoing immunosuppression to prevent acute
rejection, which puts them at risk for opportunistic infections. Viral infections are particularly …